$CBUS News

Last published 1w ago

1w agoCBUSCibus to Report Third Quarter 2026 Financial Results on November 12, 2026 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced
3mo agoCBUSCibus Reports Second Quarter Financial Results and Provides Business UpdateGlobeNewswireCommercialization execution advances in Rice and Sustainable Ingredients United States and European Union now aligned on generally treating crops with no added foreign DNA as conventionally bred Quarterly net cash
3mo agoCBUSCibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a technology company that helps farmers grow more food with fewer inputs, today announced that the company will report second quarter 2026
4mo agoCBUSEurope Recognizes Nature-Based Plant Improvement, Opening a New Pathway for CibusGlobeNewswireSAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) today welcomed a landmark decision by the European Union. For the first time, crops improved without adding foreign DNA will be treated like
5mo agoCBUSCibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value CreationGlobeNewswireSAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced
6mo agoCBUSCibus Reports First Quarter Financial Results and Provides Business UpdateGlobeNewswireSAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its
6mo agoCBUSCibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and ProductionGlobeNewswireSAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of high-value plant traits, today announced the transfer of
6mo agoCBUSCibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report
7mo agoCBUSCibus Announces the Election of Thomas Urban to Board of DirectorsGlobeNewswireSAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced
7mo agoCBUSCibus, Inc. Announces Pricing of Public Offering of Class A Common StockGlobeNewswireSAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced
7mo agoCBUSCibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded WarrantsGlobeNewswireSAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced
8mo agoCBUSCibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report
9mo agoCBUSCibus Partnering with The John Innes Centre for UK Government's Farming Innovation Programme Precision Breeding InitiativeGlobeNewswireCibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years SAN
9mo agoCBUSCibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common StockGlobeNewswireSAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced
9mo agoCBUSCibus, Inc. Announces Proposed Public Offering of Class A Common StockGlobeNewswireSAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced
10mo agoCBUSCibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin AmericaGlobeNewswireNonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean Expected to build on success under the
11mo agoCBUSCibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and CouncilGlobeNewswirePolitical agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus' plans to bring improved traits to European growers The agreed
12mo agoCBUSCibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025GlobeNewswireWith the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to
1y agoCBUSCibus Announces the Election of Craig Wichner to Board of DirectorsGlobeNewswireSAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Craig Wichner
1y agoCBUSCibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report
1y agoCBUSCibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene EditingGlobeNewswireSAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced its agreement
1y agoCBUSCibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited CanolaGlobeNewswireField testing confirms efficacy of HT2 trait in Canola under real-world conditions HT2 trait will be offered to potential seed licensing partners for introduction into commercial Canola seed products SAN DIEGO, Oct.
1y agoCBUS MGRCCibus Announces the Election of Kimberly A. Box to Board of DirectorsGlobeNewswireSAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc.
1y agoCBUSCibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025GlobeNewswireSAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter
1y agoCBUSCibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance TraitGlobeNewswireCibus and Centro Internacional de Agricultura Tropical (CIAT) have entered into an agreement to introduce Cibus' proprietary herbicide tolerance trait into elite rice germplasm for Latin America Agreement represents
1y agoCBUSCibus, Inc. (CBUS) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoCBUSCibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025GlobeNewswireStreamlining operational focus on Rice herbicide tolerance traits and partner-funded and/or supported programs, expected to reduce annual cash usage to approximately $30 million by 2026 Commercialization of Rice
1y agoCBUSCibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report
1y agoCBUSCibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue OpportunitiesGlobeNewswirePreviously Announced Strategy Focus Prioritizes Opportunities in Rice and Biofragrance Products and Sustainable Ingredients with Initiatives Expected to Reduce Annual Net Cash Usage to Approximately $30M by 2026 Cibus
1y agoCBUSThe U.S. Food and Drug Administration Completes Review of Cibus' Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock FeedGlobeNewswireSAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that it has
1y agoCBUSCibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in FarmingGlobeNewswireResearchers at the John Innes Centre (JIC) have discovered a genetic mutation with the potential to enhance nutrient uptake and reduce the need for artificial fertilizers Cibus and JIC have agreed on a collaboration
1y agoCBUSCibus, Inc. Announces Closing of $27.5 Million Public OfferingGlobeNewswireSAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits
1y agoCBUSUSDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology RegulationsGlobeNewswireSAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that its most
1y agoCBUSCibus, Inc. Announces Pricing of $27.5 Million Public OfferingGlobeNewswireSAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits
1y agoCBUSCibus, Inc. Announces Proposed Public OfferingGlobeNewswireSAN DIEGO, June 04, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits
1y agoCBUSCibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside ChatGlobeNewswireSAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or
1y agoCBUSCibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company ShowcaseGlobeNewswireSAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or
1y agoCBUSCibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025GlobeNewswireRice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with
1y agoCBUSEcuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional BreedingGlobeNewswireSAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that the
1y agoCBUSCibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic
1y agoCBUSUSDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not RegulatedGlobeNewswireSAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that two of
1y agoCBUSCibus Reports Fourth Quarter Financial Results and Provides Business UpdateGlobeNewswireA major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) or gene editing legislation for the EU; California Rice Commission approved
1y agoCBUSCibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves ForwardGlobeNewswireLegislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such as gene editing, to contribute to more sustainable agriculture, climate
1y agoCBUSCibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference CallGlobeNewswireSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic
1y agoCBUSCibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in CanolaGlobeNewswireInitial bioassay data for Cibus' third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment Cibus' white mold resistance traits are expected
1y agoCBUSCibus Announces Leadership Change and CEO Succession PlanGlobeNewswireSAN DIEGO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties,
1y agoCBUSCibus Announces Important Update to Rice Gene Editing Conversion RatesGlobeNewswireSAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties,
1y agoCBUS CLLS MGX CLXTTotus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial OfficerGlobeNewswireEMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the
1y agoCBUSCibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq's Minimum Price in Accordance with Nasdaq RulesGlobeNewswireSAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits
1y agoCBUSCibus' Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant TraitsGlobeNewswireCulmination of Advances in Gene Editing Efficiency and Process Improvements Drives Standardization of Cibus' Gene Editing System Delivering Traits in a Customer's Elite Germplasm in less than 12 Months Cibus Announces